U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07367516) titled 'Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer' on Jan. 18.
Brief Summary: The Phase Ib stage of this study primarily aims to evaluate the tolerance and safety of TQB6411 Injection in subjects with recurrent or metastatic Esophageal cancer who have previously failed treatment with PD-1/PD-L1 monoclonal antibodies combined with platinum-based chemotherapy. The Phase II stage primarily aims to evaluate the efficacy of TQB6411 Injection in this same patient population.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Esophageal Cancer
Intervention:
DRUG: TQB6411 Injection
TQB641...